Skip to content

Hereditary C1 Esterase Inhibitor Deficiency Dysfunctional Factor C0398776

Published: July 22, 2026Updated: August 20, 2026

Hereditary angioedema caused by a C1 inhibitor protein that is present but does not work properly. Leads to recurrent episodes of swelling in various body parts. Managed with specific therapies and preventive measures.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Laryngeal edema

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Abdominal pain

(gastrointestinal)

Swelling of extremities

(integumentary)

Headache

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

C1 esterase inhibitor replacement therapy

Intravenous or subcutaneous administration of C1 esterase inhibitor concentrate to replace deficient or dysfunctional protein, reducing frequency and severity of angioedema attacks.

medication
3

Bradykinin B2 receptor antagonist

Subcutaneous injection that blocks bradykinin receptors, effectively terminating acute angioedema episodes by inhibiting the pathway causing swelling.

medication

Additional treatment options

Plasma kallikrein inhibitor

Subcutaneous injection that inhibits plasma kallikrein, preventing bradykinin formation and reducing angioedema attack severity and duration.

medication

Trigger avoidance and attack preparedness

Identification and avoidance of individual triggers such as stress, infection, or certain medications; maintaining emergency medication access and carrying medical alert identification.

lifestyle

Regular specialist follow-up and attack diary

Routine assessment by immunology or hematology specialists to monitor attack frequency, adjust prophylaxis, and evaluate treatment response using patient-maintained attack diaries.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hereditary C1 Esterase Inhibitor Deficiency Dysfunctional Factor C0398776?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Maurer M, Magerl M, Ansotegui I, et al. The international WAO/EAACI guideline for the management of hereditary angioedema - the 2021 revision and update. World Allergy Organ J. 2021.

guideline2021
2

Busse PJ, Christiansen SC. Hereditary Angioedema. N Engl J Med. 2020.

review2020
3

Banerji A, Riedl MA, Bernstein JA, et al. Efficacy of lanadelumab in patients with hereditary angioedema: Results from the HELP study. Lancet Respir Med. 2018.

clinical_trial2018
4

Liu S, Wang X, Xu Y, et al. Efficacy and safety of C1 esterase inhibitor for hereditary angioedema: A systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Hereditary C1 Esterase Inhibitor Deficiency Dysfunctional Factor C0398776. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy